<DOC>
	<DOCNO>NCT01268761</DOCNO>
	<brief_summary>The aim study analyze effectiveness GnRh antagonist treatment early ovarian hyperstimulation syndrome .</brief_summary>
	<brief_title>GnRH Antagonist Treatment Early Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description>Ovarian hyperstimulation syndrome ( OHSS ) serious complication ovarian stimulation protocol . Gonadotrophin-releasing hormone ( GnRH ) antagonist administration luteal phase recently propose new approach management patient establish severe OHSS We analyze response egg donor moderate- severe early ovarian hyperstimulation syndrome GnRH antagonist stimulation protocol administration daily dose GnRH antagonist ( Cetrorelix 0.25 ) 7 day second day oocyte retrieval compare placebo ( saline solution ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Egg donor Volunteers . 1835 year old Healthy BMI &lt; 30 OHHS oocyte retrieval define ascitis &gt; 9 cm2 associate abdominal pain , sickness , abdominal distention , haematocrit ( Ht ) &gt; 45 % white blood cell count &gt; 15,000/mm3 creatine &gt; 1.2 mg/dl transaminase &gt; 40 IU/liter BMI &gt; 30 Allergy GnRH antagonist</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Ovarian hyperstimulation syndrome ( OHSS )</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>Ascitis .</keyword>
</DOC>